Evidence map›Paper›PMID 33879019›Full record

ArticleEmerging microbes & infections2021

Emergence of oxacillinase-181 carbapenemase-producing diarrheagenic

Isaac Prah, Alafate Ayibieke, Samiratu Mahazu, Chihiro Tani Sassa, Takaya Hayashi, Shoji Yamaoka, Toshihiko Suzuki, Shiroh Iwanaga, Anthony Ablordey, Ryoichi Saito

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Genomic landscape ofApplied and environmental microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Emergence of OXA-48-like Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2026
    Article
  10. ConfrontingInfection and drug resistance · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Genomic characterization of aFrontiers in cellular and infection microbiology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. High Frequency of Antibiotic Resistance Genes (ARGs) in the Lerma River Basin, Mexico.International journal of environmental research and public health · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Isaac PrahDepartment of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Alafate AyibiekeDepartment of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Samiratu MahazuDepartment of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Chihiro Tani SassaDepartment of Clinical Laboratory, Tokyo Medical and Dental University Medical Hospital, Tokyo, Japan.
Takaya HayashiDepartment of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Shoji YamaokaDepartment of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Toshihiko SuzukiDepartment of Bacterial Pathogenesis, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.ORCID https://orcid.org/0000-0003-3853-0106
Shiroh IwanagaDepartment of Environmental Parasitology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Anthony AblordeyBacteriology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Ryoichi SaitoDepartment of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.ORCID https://orcid.org/0000-0003-3398-8572

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence and spread of carbapenemase-producing bacteria are serious threats to public health. We characterized two OXA-181-producing

Indexed as

Anti-Bacterial Agentsbeta-LactamasesDiarrheaEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsGhanaHumansMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial Agentsbeta-LactamasesEscherichia coli Proteinsoxacillinasediarrheagenic E. coliIncFIC(FII) and B4/H24RxC cladeIncX3oxacillinase-181ST410

Identifiers

PMID33879019
PMCPMC8110189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.